Is AI the cure for the world's ailing drug industry?
When a Canadian company called Deep Genomics announced that it had used artificial intelligence to solve a long-standing mystery about a genetic disorder called Wilson’s disease — and, what’s more, had used another deep-learning platform to identify a potential treatment — there was a flurry of excitement in the drug development world. The apparent milestone, which the company hailed as the "first-ever A.I.-discovered therapeutic candidate," got echoing headlines from dozens of news outlets, and the 5-year-old startup received a $40 million endorsement in the form of a fresh round of venture capital funding.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063